Home / EMCURE.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does EMCURE.NS make money? Does EMCURE.NS have pricing power? What's the Earnings Whisper? Will EMCURE.NS profit more as the business scales? What is EMCURE.NS's management track record? Is EMCURE.NS's current price justified?

Emcure Pharmaceuticals Ltd.

₹1820.6 +$417.25 (+29.73%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹1836

Day Range

₹1816.2₹1849.3

Year Range

₹1306.5₹2100.7

Market Cap

345.39B

AVG Volume

176.13K

Trailing/Forward PE

34.13/22.87

PEG ratio

1.2

Dividend Yield

0.20%

Next Earnings Date

2026-11-03

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

EMCURE.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
26 Q1	96.83B
25 Q4	92.04B
25 Q3	87.62B
25 Q2	83.62B
25 Q1	80.94B

Net Income (INR) · TTM

EMCURE.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
26 Q1	10.11B
25 Q4	9.24B
25 Q3	8.7B
25 Q2	7.93B
25 Q1	7.44B

Operating Income (INR) · TTM

EMCURE.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
26 Q1	14.68B
25 Q4	13.74B
25 Q3	12.87B
25 Q2	11.97B
25 Q1	11.46B

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Emcure Pharmaceuticals Ltd.

Video analysis: EMCURE.NS

News: EMCURE.NS

Similar companies